|
Real-time
Euronext Paris
17:17:30 08/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 1.698 EUR | -0.12% |
|
-4.71% | +5.99% |
| 09-04 | Laure-Hélène Mercier takes over as chair of Poxel's board |  |
| 08-14 | Innate Pharma S.A. - Special Call |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Stocks
- IPH Stock
- Consensus Innate Pharma
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
